Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Critical Illness × Genitourinary × Clear all

Phase

Status

Unknown 1 Terminated 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1

Conditions

Prostatic Neoplasms 615 Urinary Bladder Neoplasms 227 Carcinoma, Renal Cell 167 Kidney Neoplasms 90 Neoplasms 68 Carcinoma, Transitional Cell 59 Breast Neoplasms 54 Melanoma 33 Ovarian Neoplasms 31 Neoplasm Metastasis 31 Stomach Neoplasms 30 Non-Muscle Invasive Bladder Neoplasms 30 Lung Neoplasms 30 Colorectal Neoplasms 28 Recurrence 26 Carcinoma, Non-Small-Cell Lung 24 Pancreatic Neoplasms 23 Colonic Neoplasms 23 Esophageal Neoplasms 19 Wilms Tumor 18 Uterine Cervical Neoplasms 17 Urologic Neoplasms 17 Disease 17 Head and Neck Neoplasms 16 Carcinoma, Hepatocellular 16 Prostatic Hyperplasia 15 Metastatic Castration-resistant Prostate Cancer 15 Endometrial Neoplasms 15 Testicular Neoplasms 14 Sarcoma 14

Interventions

Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02531412 2017-01-04

SPIROCAN

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown

Neoplasms, Critical Illness, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡